NeuroOne Medical Technologies Corporation Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
NeuroOne Medical Technologies Corporation (NMTC) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 4.10% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2026-08-13
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2026-06-30 was 4.10%, a 2.50% increase year-over-year.
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2026-03-31 was 3.60%, a 16.28% decline year-over-year.
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2025-12-31 was 3.70%.
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2025-06-30 was 4.00%.
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2025 was 4.00%, a 13.04% decline from fiscal 2024.
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2024 was 4.60%, a 24.32% increase from fiscal 2023.
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2023 was 3.70%, a 60.87% increase from fiscal 2022.
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2022 was 2.30%, a 283.33% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 4.10% 10-Q · filed 2026-08-13 | 3.70% 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | 3.60% 10-Q/A · filed 2026-06-12 | 3.60% 10-Q/A · filed 2026-06-12 | |||
| 2025-12-31 | 3.70% 10-Q · filed 2026-02-17 | ||||
| 2025-09-30 | 4.00% 10-K · filed 2025-12-17 | ||||
| 2025-06-30 | 4.00% 10-Q · filed 2026-08-13 | 4.00% 10-Q · filed 2026-08-13 | |||
| 2025-03-31 | 4.30% 10-Q/A · filed 2026-06-12 | 4.30% 10-Q/A · filed 2026-06-12 | |||
| 2024-09-30 | 4.60% 10-K · filed 2025-12-17 | ||||
| 2024-06-30 | 4.60% 10-Q · filed 2025-08-14 | ||||
| 2024-03-31 | 4.30% 10-Q · filed 2025-05-13 | 4.60% 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | 4.70% 10-Q · filed 2025-02-12 | ||||
| 2023-09-30 | 3.70% 10-K · filed 2024-12-17 | ||||
| 2023-06-30 | 3.60% 10-Q · filed 2024-08-14 | 3.70% 10-Q · filed 2024-08-14 | |||
| 2023-03-31 | 3.70% 10-Q · filed 2024-05-14 | 3.90% 10-Q · filed 2024-05-14 | |||
| 2022-12-31 | 4.00% 10-Q · filed 2024-02-13 | ||||
| 2022-09-30 | 2.30% 10-K · filed 2023-12-15 | ||||
| 2022-08-02 | 2.90% 10-Q · filed 2024-02-13 | ||||
| 2022-06-30 | 2.80% 10-Q · filed 2023-08-14 | 2.30% 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | 1.60% 10-Q · filed 2022-05-12 | 1.60% 10-Q · filed 2023-05-12 | |||
| 2021-12-31 | 1.10% 10-Q · filed 2023-02-13 | ||||
| 2021-09-30 | 0.60% 10-K · filed 2022-12-22 | ||||
| 2021-06-30 | 1.00% 10-Q · filed 2022-08-11 | 0.60% 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | 0.60% 10-Q · filed 2022-05-12 | 0.60% 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | 0.50% 10-Q · filed 2022-02-14 | ||||
| 2020-09-30 | 1.40% 10-K/A · filed 2022-05-31 | ||||
| 2020-06-30 | 0.40% 10-Q · filed 2021-08-13 | 1.50% 10-Q · filed 2021-08-13 | |||
| 2020-03-31 | 1.40% 10-Q · filed 2021-05-14 | 1.70% 10-Q · filed 2021-05-14 | |||
| 2018-12-31 | 2.85% 10-Q · filed 2019-02-14 | ||||
| 2018-09-30 | 2.80% 10-KT · filed 2019-03-18 | ||||
| 2018-03-31 | 2.60% 10-Q · filed 2018-05-16 | ||||
| 2017-12-31 | 1.90% 10-K · filed 2018-04-16 | ||||
| 2017-09-30 | 0.00% 10-Q · filed 2017-11-14 | 1.90% 10-KT · filed 2019-03-18 | |||
| 2017-06-30 | 1.90% 10-Q · filed 2018-08-13 | 1.90% 10-Q · filed 2018-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |